RxDoctor Payments Data

Clinton Atkinson, MD

Vascular Surgery · Pinehurst, NCNPI 1083620280

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.1% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 63.6% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $995, 2.6 times the $385 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in NC, where the typical reported total is $2,786.

$2,449in general payments, 2019–2025

Across 54 payments — averaging $45.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Johnson & Johnson$181
  • Silk Road Medical, Inc.$169
  • Venclose Inc.$131
  • Organogenesis Inc.$125
  • W. L. Gore & Associates, Inc.$74
  • plus $213 from 8 others
$111,717in research payments, 2019–2025

Across 14 payments — averaging $7979.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$112K

What the payments were for

  • Travel & lodging$24110%
  • Food & beverage$2,20790%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)29$1,557
Johnson & Johnson2$181
Silk Road Medical, Inc.2$169
Venclose Inc.1$131
Organogenesis Inc.5$125
W. L. Gore & Associates, Inc.4$74
Cook Medical LLC3$50
Abbott2$42
Solventum Corporation1$31
Boston Scientific1$29
Shockwave Medical, Inc1$20
Covidien LP1$20
Pfizer1$15
Cashflow Solutions, LLC1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,449 in reported general payments places this provider in the 45th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$129,659
Medicare patients
473
Services billed
830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol67$972
ClopidogrelClopidogrel Bisulfate32$225
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen53$180

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →